Molecular BiologybioRxivPreprint
Development of Nanobodies as first-in-class inhibitors for the NEDP1 deNEDDylating enzyme
Naima Abidi, Hélène Trauchessec, Gholamreza Hassanzadeh‐Ghassabeh…·Dimitris P. Xirodimas
This paper develops and characterizes nanobodies as first-in-class inhibitors of NEDP1, showing high-affinity binding and specific inhibition of its deconjugating activity.
4 citations